Expert Analysis

3rd Circ.'s Geico Ruling May Encourage Healthcare Arbitration

The Third Circuit's recent decision in Geico v. Mount Prospect, finding that claims under New Jersey's Insurance F... (more story)

Proposed Cannabis Reschedule Sidesteps State Law Effects

The U.S. Department of Justice's recent proposal to move cannabis to Schedule III of the Controlled Substances Act... (more story)

A Changing Regulatory Landscape For Weight Loss Drugs

As drugs originally approved to treat diabetes become increasingly popular for weight loss purposes, federal and s... (more story)

Deals & Corporate Governance More

Fla. Medicare Companies Get Class Cert. In Suit Against USAA

A Florida state court judge granted certification to a class of Medicare-contracted businesses suing USAA Casualty Insurance Co. over allegations the insurer withheld policy information and intentionally passe... (more story)

J&J To Pay $1.25B For Global Rights To Eczema Treatment

Johnson & Johnson has agreed to buy the rights to an experimental treatment for eczema from Baker McKenzie-advised Numab Therapeutics for approximately $1.25 billion, the companies announced on Tuesday.

Medical Test Maker To Liquidate After FDA Slams COVID Kits

Medical test maker Cue Health filed for Chapter 7 liquidation in Delaware bankruptcy court Tuesday with more than $50 million in debt, two weeks after federal regulators warned customers to throw out its COVID... (more story)

DC Circ. Decision May Lead To Tighter 340B Pharma Contracts

A D.C. Circuit decision last week holding that the federal 340B drug pricing program doesn't bar drugmakers from imposing contractual conditions on contract pharmacies could embolden them to impose tougher res... (more story)

Healthcare REIT Nabs $800M Despite Tenant Turbulence

Medical Properties Trust Inc. announced Friday that the real estate investment trust has secured a £631 million ($804 million) financing from a group of investors led by real estate investment firm Song Capita... (more story)

Doc Gets 3 Mos. For Alexion Trades Despite 'Meaningful Job'

A doctor was sentenced to three months in prison Wednesday for insider trading on an Alexion Pharmaceuticals acquisition, with a Manhattan federal judge saying the defendant's treatment of critically ill, unde... (more story)

Digital Health & Technology More

Greenberg Traurig Adds IP Atty From Eversheds Sutherland

Greenberg Traurig LLP has bolstered its California bench of attorneys with an Eversheds Sutherland lawyer who has years of experience advising digital health and medical device companies on intellectual property issues.

Fla. Lab Owner Will Pay $27M To End False Billing Suit

A Florida medical lab owner who pled guilty to charges related to accusations he billed Medicare for $53 million in unnecessary genetic cancer screening tests has agreed to pay more than $27 million to resolve... (more story)

Stryker Unit And Seyfarth Attys Hit With $275K Sanctions

A Colorado federal judge has imposed $275,000 in sanctions jointly and severally on Stryker-owned Howmedica Osteonics Corp., along with Seyfarth Shaw LLP, for witness coaching and discovery violations in a bit... (more story)

Stryker Agrees To Settle Calif. Misclassification Suit

Medical device company Stryker told a California federal court Wednesday it has agreed to settle a proposed class action accusing it of misclassifying workers as overtime-exempt and failing to pay them overtim... (more story)

Lead Blood Test Maker To Plead Guilty, Pay $42M Over Defects

Medical device maker Magellan Diagnostics has agreed to pay at least $42 million and plead guilty to hiding a defect in its blood testing devices for lead that caused inaccurately low results for tens of thous... (more story)

Strategic Hiring Was The New Normal For BigLaw In 2023

The 400 largest law firms by headcount in the U.S. grew more slowly in 2023 than in the previous two years, while Kirkland & Ellis LLP surpassed the 3,000-attorney threshold, according to the latest Law360 ranking.

Policy & Compliance More

FDA Sued Over Controversial Lab Test Rule

A clinical lab trade group that has been highly critical of the U.S. Food and Drug Administration's new final rule on laboratory-developed tests filed a lawsuit late Wednesday, saying the agency doesn't have t... (more story)

Acting Boston US Atty Says Fraud Cases Still High Priority

Prosecuting a range of fraud cases despite finite resources will remain a priority for Massachusetts acting U.S. Attorney Joshua Levy as he enters his second year in the job, he told reporters on Wednesday in ... (more story)

Whistleblower Counsel Can't Get 'Exorbitant' $11.5M Fee

A Boston federal judge slashed an "exorbitant" $11.5 million fee request made by counsel for a False Claims Act whistleblower in a case involving lab testing company Fresenius Medical Care, hammering the attor... (more story)

Staffing Rule Suit, Mayo COVID Claims And An Oathless Expert

Nursing home trade groups sue over "nightmare" staffing rule, former Mayo Clinic workers get another shot at claims they were illegally fired over COVID-19 policy breaches, and an unsworn expert letter tanks a... (more story)

Alaska Opioid Suit Moves Forward In Early Loss For PBMs

An Alaska federal judge is allowing public nuisance claims to move forward against Express Scripts as pharmacy benefit managers are increasingly targeted in opioid litigation.

5th Circ. Flips Cancer-Drug Maker's Defeat In Hair Loss MDL

The Fifth Circuit has vacated a summary judgment ruling in favor of four women who say two drugmakers failed to warn consumers that their chemotherapy drug could cause hair loss, saying it was impossible for t... (more story)